Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Hay

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|December 3, 1999
The methylenetetrahydrofolate reductase gene C677T polymorphism in patients with homozygous sickle cell disease and strokeA M Cumming, A Olujohungbe, S Keeney, et al.
Annals of the Rheumatic Diseases|February 1, 1996
Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosisA L Herrick, K Illingworth, A Blann, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1994
Prothrombin fragment F1 + 2: correlations with cardiovascular risk factorsF P Rugman, J A Jenkins, J K Duguid, et al.
Journal of Clinical Pathology|April 1, 1987
Atypical bullous pyoderma gangrenosum associated with myeloid malignanciesC R Hay, A G Messenger, D W Cotton, et al.
British Journal of Haematology|November 25, 2000
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)C R Hay, T P Baglin, P W Collins, et al.
British Journal of Haematology|July 1, 1995
Development of resistance to activated protein C during pregnancyA M Cumming, R C Tait, S Fildes, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1996
Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors' Organisation Inhibitor Working PartyC R Hay, B T Colvin, C A Ludlam, et al.
British Journal of Haematology|August 1, 1997
The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic populationA M Cumming, S Keeney, A Salden, et al.
European Journal of Haematology|October 1, 1987
Granular common acute lymphoblastic leukaemia in adults: a morphological studyC R Hay, D Barnett, V James, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 20, 2002
Continuous infusion of porcine factor VIII in patients with haemophilia A and high-responding inhibitors: stability and clinical experienceP O'Gorman, D M Dimichele, C K Kasper, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|December 3, 1999
The methylenetetrahydrofolate reductase gene C677T polymorphism in patients with homozygous sickle cell disease and strokeA M Cumming, A Olujohungbe, S Keeney, et al.
Annals of the Rheumatic Diseases|February 1, 1996
Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosisA L Herrick, K Illingworth, A Blann, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1994
Prothrombin fragment F1 + 2: correlations with cardiovascular risk factorsF P Rugman, J A Jenkins, J K Duguid, et al.
Journal of Clinical Pathology|April 1, 1987
Atypical bullous pyoderma gangrenosum associated with myeloid malignanciesC R Hay, A G Messenger, D W Cotton, et al.
British Journal of Haematology|November 25, 2000
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)C R Hay, T P Baglin, P W Collins, et al.
British Journal of Haematology|July 1, 1995
Development of resistance to activated protein C during pregnancyA M Cumming, R C Tait, S Fildes, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1996
Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors' Organisation Inhibitor Working PartyC R Hay, B T Colvin, C A Ludlam, et al.
British Journal of Haematology|August 1, 1997
The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic populationA M Cumming, S Keeney, A Salden, et al.
European Journal of Haematology|October 1, 1987
Granular common acute lymphoblastic leukaemia in adults: a morphological studyC R Hay, D Barnett, V James, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 20, 2002
Continuous infusion of porcine factor VIII in patients with haemophilia A and high-responding inhibitors: stability and clinical experienceP O'Gorman, D M Dimichele, C K Kasper, et al.
Pageof 7